Skip to main content
SpringerLink
Log in

Anti-hypertensive activity of fermented dairy products containing biogenic peptides

  • Published:
Antonie van Leeuwenhoek Aims and scope Submit manuscript

Abstract

A considerable amount of research has been conducted to study the health benefits of fermented milks. One possible mechanism for the beneficial effects is the involvement of biogenic compounds, which are produced by the action of microorganisms and make the products directly beneficial without the need for live bacteria. Research on the health effects of a pasteurized sour milk, which is fermented by a starter culture containing Lactobacillus helveticus as the predominant microorganism, indicated clear evidence for the involvement of biogenic compounds. In this paper, beneficial effects of sour milk are reviewed with special attention to the effect on anti-hypertension and angiotensin-I converting enzyme inhibitory peptides identified in sour milk.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  • Adibi SA (1971) Intestinal transport of dipeptides in man: relative importance of hydrolysis and intact absorption. J. Clin. Invest. 50: 2266–2275.

    Google Scholar 

  • Adibi SA& Kim YS (1981) Peptide absorption and hydrolysis. In: Johnson LR (Ed) Physiology of the Gastrointestinal Tract (pp 1097–1122). Raven Press, New York, USA.

    Google Scholar 

  • Ames RP (1983) Negative effects of diuretic drugs on metabolic risk factors for coronary heart disease. Am. J. Cardiol. 51: 632–638.

    Google Scholar 

  • Arai K, Murota I, Hayakawa K, Kataoka M& Mitsuoka T (1980) Effects of administration of pasteurized fermented milk to mice on the life-span and intestinal flora. J. Jap. Soc. Nutr. Food Sci. 33: 219–223.

    Google Scholar 

  • Cheung HS, Wang FL, Ondetti MA, Sabo EF& Cushman DW (1980) Binding of peptide substrates and inhibitors of angiotensin-converting enzyme. J. Biol. Chem. 255: 401–407.

    Google Scholar 

  • Craft IL, Geddes D, Hyde CW, Wise IJ& Matthews DM (1968) Absorption and malabsorption of glycine and glycine peptides in man. Gut 9: 425–437.

    Google Scholar 

  • Erdos EG (1975) Angiotensin I converting enzyme. Circul. Res. 36: 247–255.

    Google Scholar 

  • Ferreira SH, Bartelt DC& Greene LJ (1970) Isolation of bradykinin-potentiating peptides from Bothrops jararaca venom. Biochemistry 9: 2583–2592.

    Google Scholar 

  • FitzGerald RJ& Meisel H (2000) Milk protein-derived peptide inhibitors of angiotensin-I-converting enzyme. Br. J. Nutr. 84 (Suppl 1: S33–S37.

    Google Scholar 

  • Fuller R (1989) Probiotics in man and animals. J. Appl. Bacteriol. 66: 365–378.

    Google Scholar 

  • Hara H, Funabiki R, Iwata M& Yamazaki K (1984) Portal absorption of small peptides in rats under unrestrained condition. J. Nutr. 114: 1122–1129.

    Google Scholar 

  • Hata Y, YamamotoM, OhniM, Nakajima K, Nakamura Y& Takano T (1996) A placebo-controlled study of the effect of sour milk on blood pressure in hypertensive subjects. Am. J. Clin. Nutr. 64: 767–771.

    Google Scholar 

  • Itakura H, Ikemoto S, Terada S& Kondo K (2001) The effect of sour milk on blood pressure in untreated hypertensive and normotensive subjects. J. Jap. Soc. Clin. Nutr. 23: 26–31.

    Google Scholar 

  • Kato H& Suzuki T (1971) Bradykinin-potentiating peptides from the venom of Agkistrodon haly blomhoffi. Isolation of five bradykinin potentiators and the amino acid sequence of two of them, potentiators B and C. Biochemistry 10: 972–980.

    Google Scholar 

  • Kim YS, Bertwhistle W& Kim YW (1972) Peptide hydrolyses in the brush border and soluble fractions of small intestinal mucosa of rat and man. J. Clin. Invest. 51: 1419–1430.

    Google Scholar 

  • Kim YS, Brophy EJ& Nicholson JA (1976) Rat intestinal brush border membrane peptidases. 2. Enzymatic properties, immunochemistry and interactions with lectins of two different forms of the enzymes. J. Biol. Chem. 251: 3206–3212.

    Google Scholar 

  • Maeno M, Yamamoto N& Takano T (1996) Identification of antihypertensive peptides from casein hydrolysate produced by a proteinase from Lactobacillus helveticus CP790. J. Dairy Sci. 73: 1316–1321.

    Google Scholar 

  • Masuda O, Nakamura Y& Takano T (1996) Antihypertensive peptides are present in aorta after oral administration of sour milk containing these peptides to spontaneously hypertensive rats. J. Nutr. 126: 3063–3068.

    Google Scholar 

  • Meisel H (1998) Overview on milk protein-derived peptides. Int. Dairy J. 8: 363–373.

    Google Scholar 

  • Mitsuoka T (1976) Taxonomy of lactic acid bacteria and medical effect of sour milk Jap. J. Dairy Food Sci. 25: A170–176.

    Google Scholar 

  • Mitsuoka T (2000) Significance of dietary modification of intestinal flora and intestinal environment. Biosci. Microflora 19: 15–25.

    Google Scholar 

  • Mock WL, Green PC& Boyer KD (1990) Specificity and pH dependence for acylproline cleavage by prolidase. J. Biol. Chem. 265: 19600–19605.

    Google Scholar 

  • Nakamura H (1987) Effects of antihypertensive drugs on plasma lipid. Am. J. Cardiol. 60: 24E–28E.

    Google Scholar 

  • Nakamura Y, Masuda O& Takano T (1996) Decrease of tissue angiotensin I-converting enzyme activity upon feeding sour milk in spontaneously hypertensive rats. Biosci. Biotech. Biochem. 60: 488–489.

    Google Scholar 

  • Nakamura Y, Yamamoto N, Sakai K, Okubo A, Yamazaki S& Takano T (1995a) Purification and characterization of angiotensin I-converting enzyme inhibitors from a sour milk. J. Dairy Sci. 78: 777–783.

    Google Scholar 

  • Nakamura Y, Yamamoto N, Sakai K& Takano T (1995b) Antihypertensive effect of sour milk and peptides isolated from it that are inhibitors to angiotensin I-converting enzyme. J. Dairy Sci. 78: 1253–1257.

    Google Scholar 

  • Ondetti MA, Rubin B& Cushman DW (1977) Design of specific inhibitors of angiotensin converting enzyme: a new class of orally active antihypertensive agents. Science 196: 441–444.

    Google Scholar 

  • Pong SF, Brooks RR, Huang CT& Moore AF (1985) Correlation between anti-hypertensive activity in rats and plasma angiotensin I-converting enzyme (ACE) inhibition in mice following oral administration of ACE inhibitors. Pharmacol. Res. Comm. 17: 331–344.

    Google Scholar 

  • Rasic JL& Kurmann JA (1978) The nutritional-physiological value of yoghurt.: In Yoghurt (pp 99–137), Tech Dairy Publ. House, Copenhagen, Denmark.

    Google Scholar 

  • Satake M, Enjoh M, Nakamura Y, Takano T, Kawamura Y, Arai S& Shimizu M (2002) Transepithelial transport of the bioactive tripeptide, Val-Pro-Pro, in human intestinal Caco-2 cell monolayers. Biosci. Biotechnol. Biochem. 66: 378–384.

    Google Scholar 

  • Sipola M, Finckenberg P, Santisteban J, Korpela R, Vapaatalo H& Nurminen ML (2001) Long-term intake of milk peptides attenuates development of hypertension in spontaneously hypertensive rats. J. Physiol. Pharmacol. 52: 745–754.

    Google Scholar 

  • Skeggs LT, Kahn JE& Shumway NP (1956) The preparation and function of the angiotensin-converting enzyme. J Exper. Med. 103: 295–299.

    Google Scholar 

  • Seseko S& Kaneko Y (1985) Cough associated with the use of captopril. Arch. Int. Med. 145: 1524.

    Google Scholar 

  • Takano T (1998) Milk derived peptides and hypertension reduction. Int. Dairy J. 8: 375–381.

    Google Scholar 

  • Takano T, Arai K, Murota I, Hayakawa K, Mizutani T& Mitsuoka T (1985) Effects of feeding sour milk on longevity and tumorigenesis in mice and rats. Bifidobacteria Microflora 4: 31–37.

    Google Scholar 

  • Unger T, Ganten D, Lang RE& Scholkens BA (1985) Persistent tissue converting enzyme inhibition following chronic treatment with Hoe498 and MK421 in spontaneously hypertensive rats. J. Cardiovascul. Pharmacol. 7: 36–41.

    Google Scholar 

  • Unger T, Kaufmann-Buhler I, Scholkens B& Ganten D (1981) Brain converting enzyme inhibition: a possible mechanism for the antihypertensive action of Captopril in spontaneously hypertensive rats. Euro. J. Pharmacol. 70: 467–478.

    Google Scholar 

  • Velletri P& Bean BL (1982) The effect of Captopril on rat aortic angiotensin-converting enzyme. J. Cardiovascul. Pharmacol. 4: 315–325.

    Google Scholar 

  • Wada K, Arai K, Takano T, Murota I, Hayakawa K, Mizutani T& Mitsuoka T. (1984) Effect of sour milk on the renal disorder and intestinal flora. In: Mitsuoka T (Ed) Intestinal Flora and Geriatric Diseases (pp 175–197). Gakkai-Shuppan Center, Tokyo, Japan.

    Google Scholar 

  • Yamamoto N (1997) Antihypertensive peptides derived from food proteins. Biopolymer 43: 129–134.

    Google Scholar 

  • Yamamoto N, Akino A& Takano T (1993) Purification and specificity of a cell-wall-associated proteinase from Lactobacillus helveticus CP790. J. Biochem. 114: 740–745.

    Google Scholar 

  • Yamamoto N, Akino A& Takano T (1994) Antihypertensive effects of different kinds of fermented milk in spontaneously hypertension rats. Biosci. Biotech. Biochem. 58: 776–778.

    Google Scholar 

  • Yamamoto N, Akino A& Takano T (1994a) Antihypertensive effects of peptides derived from casein by an extracellular proteinase from Lactobacillus helveticus CP790. J. Dairy Sci. 77: 917–922.

    Google Scholar 

  • Yamamoto N, Maeno M& Takano T (1999) Purification and characterization of an antihypertensive peptide form a yogurt-like product fermented by Lactobacillus helveticus CPN4. J. Dairy Sci. 82: 1388–1393.

    Google Scholar 

  • Yoshimoto T, Fischl M, Orlowski RC& Walter R (1978) Postproline cleaving enzyme and post-proline dipeptidyl aminopeptidase comparison of two peptidases with high specificity foe proline residues. J. Biol. Chem. 253: 3708–3716.

    Google Scholar 

  • Yoshioka M, Erickson RH, Woodley JF, Gulli R, Guan D& Kim YS (1987) Role of rat intestinal brush-border membrane angiotensin-converting enzyme in dietary protein digestion. Am. J. Physiol. 253: G781–G786.

    Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Frontiers Laboratory, Calpis Co. Ltd, R&D Center, 11-10, 5-chome Fuchinobe, Sagamihara-shi, Kanagawa, 229-0006, Japan

    Dr. T. Takano

Authors
  1. Dr. T. Takano
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Takano, D.T. Anti-hypertensive activity of fermented dairy products containing biogenic peptides. Antonie Van Leeuwenhoek 82, 333–340 (2002). https://doi.org/10.1023/A:1020600119907

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1023/A:1020600119907

Search

Navigation